MassDevice.com +5 | The top 5 medtech stories for May 25, 2017

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Artificial pancreas: These companies are racing to make one Medical device companies are close to achieving the holy grail of diabetes treatment: a combined glucose sensor, control algorithm and insulin infusion device that effectively acts as an “artificial pancreas.” We explain more in the newest video from editors at MassDevice’s sister publication Medical Design & Outsourcing. (And for a deeper dive, check out our recent roundup of companies in the race.) Read more 4. Ultrasound-drug combo treats pulmonary embolism in less time with fewer drugs When venous clots break off and travel through a patient’s circulatory system, they can become trapped in the lung and block blood flow. This strains the heart’s ability to pump blood through the lungs and can ultimately lead to heart failure. Traditionally, patients with pulmonary embolisms are treated overnight with systemic infusions of tissue plasminogen activator. Read more 3. Australia mulls green-lighting overseas-approved devices Australia’s Therapeutic Goods Administration this week proposed to a...
Source: Mass Device - Category: Medical Devices Authors: Tags: News Well Plus 5 Source Type: news